Trial Profile
Special Drug Use-results Survey for long-term use of Doxil injection 20mg (ovarian cancer aggravated after chemotherapy)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2017
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 19 Dec 2014 New trial record